Title |
The necessity of nuclear reactors for targeted radionuclide therapies
|
---|---|
Published in |
Trends in Biotechnology, May 2013
|
DOI | 10.1016/j.tibtech.2013.04.007 |
Pubmed ID | |
Authors |
Gerard C. Krijger, Bernard Ponsard, Mark Harfensteller, Hubert T. Wolterbeek, Johannes W.F. Nijsen |
Abstract |
Nuclear medicine has been contributing towards personalized therapies. Nuclear reactors are required for the working horses of both diagnosis and treatment, i.e., Tc-99m and I-131. In fact, reactors will remain necessary to fulfill the demand for a variety of radionuclides and are essential in the expanding field of targeted radionuclide therapies for cancer. However, the main reactors involved in the global supply are ageing and expected to shut down before 2025. Therefore, the fields of (nuclear) medicine, nuclear industry and politics share a global responsibility, faced with the task to secure future access to suitable nuclear reactors. At the same time, alternative production routes should be industrialized. For this, a coordinating entity should be put into place. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 21% |
Student > Master | 9 | 19% |
Student > Doctoral Student | 4 | 8% |
Researcher | 4 | 8% |
Other | 3 | 6% |
Other | 6 | 13% |
Unknown | 12 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Physics and Astronomy | 7 | 15% |
Medicine and Dentistry | 5 | 10% |
Engineering | 5 | 10% |
Agricultural and Biological Sciences | 4 | 8% |
Chemistry | 4 | 8% |
Other | 7 | 15% |
Unknown | 16 | 33% |